Forensic and Pharmaceutical Risks in the Organization of Pharmacotherapy of Covid, Post-Covid and Long-Covid Disorders. COVID-19 and Vaccination Practice Standards.

Abstract

The COVID-19 pandemic has strained the healthcare system. It is important to consider forensic and pharmaceutical risks in the organization of vaccination practices and pharmacotherapy of covid, post-covid and long-covid disorders. Scientific sources on the clinical characteristics of SARS-CoV-2, COVID-19 have been systematized. The standards of vaccination practice (immunization, vaccination) of different age categories of the population in Ukraine, England, USA, Belgium, Greece, Japan, and Portugal were analyzed. Proven that the organization of pharmacotherapy schemes is difficult due to the presence of mixed infections, comorbid and complicated forms of diseases, the formation of virus resistance to drugs, and the development of secondary immunological insufficiency. The risks of pharmacotherapy with regard to mortality in patients with COVID-19 due to the development of severe lung lesions and systemic multiorgan pathology are indicated. Schemes of combined pharmacotherapy including antiviral, anti-inflammatory drugs, glucocorticosteroids, genetically engineered biological drugs and "targeted" basic anti-inflammatory drugs were analyzed. The theoretical prerequisites for "repositioning" (drug repurposing) for the treatment of COVID-19 and ego complications are indicated. New directions of anti-inflammatory pharmacotherapy of COVID-19 Janus kinase with a range of anti-inflammatory and antiviral effects were noted. Emphasis was placed on the importance of informing health care professionals about forensic pharmaceutical risks in pharmacotherapy and vaccination practices. The relevance of legal support for medical activity in the conditions of a pandemic was noted. Further research is ongoing.

Immunological Criteria of Autoaggression of Bronchial Asthma: Markers for Prediction of the Course and Selection of Adequate Pharmacotherapy

“…The study is a fragment of the research work of Lviv Medical University LLC on the topic "Improving the system of drug circulation during pharmacotherapy on the basis of evidence-based and clinical pharmacy, organization, technology, biopharmacy and pharmaceutical law" (state registration number 0120U105348, implementation period [2021][2022][2023][2024][2025][2026].…”

Illegal Narcotics Circulation During the Coronavirus Disease Pandemic: Forensic Pharmacy, Pharmaceutical Business Organization and Criminal Law as a Foundation for the Interdisciplinary Study of Smuggling

“…Kaasnevate haigustega narkomaanide arsti-ja farmaatsiaabi korralduse praeguse taseme uurimine EL-i riikides, nagu Eesti, suurendab õiguskaitseorganite võitlust narkokaubanduse ja salakaubaveo vastu COVID-19 pandeemia ajal. [11][12][13][14][15][16][17][18][19][20][21].…”

Polydrug Addiction: Multidisciplinary Forensic and Pharmaceutical, Organizational and Legal, and Technological Study of Factors of Formation and Development

“…Psychoactive alcohol-containing liquids and their combinations with simultaneous use: alcoholic beverages, beer, psychoactive alcoholic preparations, preparations with psychoactive narcotic, psychotropic substances. According to WHO terminology, ethyl alcohol belongs to psychoactive substances, it is used to produce various medicinal forms of drugs, alcoholic preparations, as well as in the production of low-alcohol and strong alcoholic beverages [62][63][64][65][66][67][68][69][70][71][72].…”